161 related articles for article (PubMed ID: 33904046)
1. The Role of Physician Professional Networks in Physicians' Receipt of Pharmaceutical and Medical Device Industries' Payments.
Winn AN; Mitchell AP; Fergestrom N; Neuner JM; Trogdon JG
J Gen Intern Med; 2021 Jul; 36(7):1858-1866. PubMed ID: 33904046
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology.
Mitchell AP; Winn AN; Lund JL; Dusetzina SB
Oncologist; 2019 May; 24(5):632-639. PubMed ID: 30728276
[TBL] [Abstract][Full Text] [Related]
3. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
[TBL] [Abstract][Full Text] [Related]
5. Types and Distribution of Payments From Industry to Physicians in 2015.
Tringale KR; Marshall D; Mackey TK; Connor M; Murphy JD; Hattangadi-Gluth JA
JAMA; 2017 May; 317(17):1774-1784. PubMed ID: 28464140
[TBL] [Abstract][Full Text] [Related]
6. Medical Device Firm Payments To Physicians Exceed What Drug Companies Pay Physicians, Target Surgical Specialists.
Bergman A; Grennan M; Swanson A
Health Aff (Millwood); 2021 Apr; 40(4):603-612. PubMed ID: 33819100
[TBL] [Abstract][Full Text] [Related]
7. The Association between Industry Payments and Brand-Name Prescriptions in Otolaryngologists.
Morse E; Hanna J; Mehra S
Otolaryngol Head Neck Surg; 2019 Oct; 161(4):605-612. PubMed ID: 31547772
[TBL] [Abstract][Full Text] [Related]
8. Association between industry payments and prescriptions of long-acting insulin: An observational study with propensity score matching.
Inoue K; Tsugawa Y; Mangione CM; Duru OK
PLoS Med; 2021 Jun; 18(6):e1003645. PubMed ID: 34061852
[TBL] [Abstract][Full Text] [Related]
9. Association between physician characteristics and payments from industry in 2015-2017: observational study.
Inoue K; Blumenthal DM; Elashoff D; Tsugawa Y
BMJ Open; 2019 Sep; 9(9):e031010. PubMed ID: 31542759
[TBL] [Abstract][Full Text] [Related]
10. Association between industry payments for opioid products and physicians' prescription of opioids: observational study with propensity-score matching.
Inoue K; Figueroa JF; Orav EJ; Tsugawa Y
J Epidemiol Community Health; 2020 Aug; 74(8):647-654. PubMed ID: 32350126
[TBL] [Abstract][Full Text] [Related]
11. Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin.
Hartung DM; Johnston K; Cohen DM; Nguyen T; Deodhar A; Bourdette DN
JAMA Netw Open; 2018 Jun; 1(2):e180482. PubMed ID: 30646086
[TBL] [Abstract][Full Text] [Related]
12. Characteristics Of Biomedical Industry Payments To Teaching Hospitals.
Anderson TS; Gellad WF; Good CB
Health Aff (Millwood); 2020 Sep; 39(9):1583-1591. PubMed ID: 32897778
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Advanced Practice Nurses Receiving Top Industry Payments and Their Practice Settings: a Cross-sectional Study.
Grundy Q; Held F; Hart D; Baugh CM; Ladd E; Campbell E; Bero L
J Gen Intern Med; 2024 May; 39(7):1142-1148. PubMed ID: 37962732
[TBL] [Abstract][Full Text] [Related]
14. Physician-Industry Interactions and Anti-Vascular Endothelial Growth Factor Use Among US Ophthalmologists.
Taylor SC; Huecker JB; Gordon MO; Vollman DE; Apte RS
JAMA Ophthalmol; 2016 Aug; 134(8):897-903. PubMed ID: 27356110
[TBL] [Abstract][Full Text] [Related]
15. Association of Pharmaceutical Industry Payments to Physicians With Prescription and Medicare Expenditures for Pimavanserin.
Mehta HB; Moore TJ; Alexander GC
Psychiatr Serv; 2021 Jan; 72(1):77-80. PubMed ID: 32838675
[TBL] [Abstract][Full Text] [Related]
16. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
[TBL] [Abstract][Full Text] [Related]
17. Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018.
Nalleballe K; Sheng S; Li C; Mahashabde R; Annapureddy AR; Mudassar K; Pothineni K; Veerapaneni P; Harada Y; Chilkulwar A; Ranabothu S; Brown A; Kapoor N; Onteddu S
Stroke; 2020 Apr; 51(4):1339-1343. PubMed ID: 32078482
[TBL] [Abstract][Full Text] [Related]
18. Industry payments and physicians prescriptions: Effect of a payment restriction policy.
Ansari B
Soc Sci Med; 2021 Jun; 278():113942. PubMed ID: 33892242
[TBL] [Abstract][Full Text] [Related]
19. Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey.
Pham-Kanter G; Mello MM; Lehmann LS; Campbell EG; Carpenter D
J Gen Intern Med; 2017 Jul; 32(7):767-774. PubMed ID: 28265803
[TBL] [Abstract][Full Text] [Related]
20. Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs.
Perlis RH; Perlis CS
PLoS One; 2016; 11(5):e0155474. PubMed ID: 27183221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
